Examples of using T-cell in English and their translations into German
{-}
-
Colloquial
-
Medicine
-
Official
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
T-Cell Army.
Peripheral T-cell redistribution i. e.
T-Cell acute lymphocytic leukemia T-ALL.
And the aspergillus is a t-cell issue.
But the T-cell in your DNA that would normally fight it is dormant.
People also translate
Can be of B-cell type(left)- or T-cell type right.
The drug inhibited T-cell proliferation as a function of concentration.
The healers each had 5 photographs, name and T-cell count.
Immunological defence: A T-cell is made fit for the fight against pathogens by a dendritic cell.
Mean increase from baseline in CD4+ T-cell count cells/mm3.
Responses were seen in different immunophenotypes of ALL, including pre-B cell and T-cell.
Recombinant monoclonal IgG1 antibody against T-cell immune response cDNA 7.
No sign of meningitis, your t-Cell count is good... which leaves us squarely in the dark as to my condition, except that it's getting worse.
I don't know which thing it is that keeps my T-cell count high, so I try it all.
T-cell adhesion to blood vessel endothelium and/or transmigration into tissue occurred after start of blinatumomab infusion or dose escalation.
How exactly does the pumpkin seed looking thing connect to the PacMan looking T-Cell thing?
The incidence of lymphoma(B-cell and T-cell) cases was higher in clinical trials than expected in the general population.
Levels of zombie virus fell, cell metabolism was normal,but then something led to a T-cell crash, then re-infection, then.
The IC50 values for imatinib mesylate-inhibited T-cell proliferation stimulated by DCs and PHA were 3.9 μM and 2.9 μM, respectively….
Aside from the roles played by genetic and environmental factors, someof the main pathological processes proposed are described below: T-cell bypass.
We will improve and extend our technology by selection of general T-cell targets and clinically attractive tracers.
Some patients with Crohn's disease or ulcerative colitis who have received Remicade have developed arare type of cancer called Hepatosplenic T-cell Lymphoma.
The treatment should be monitored by measuring neutralising antibodies and T-Cell response against AAV1 and LPLS447X and T-Cell response at baseline as well as 6 and 12 months after treatment.
Pichler(University Hospital, Berne; project 80/01) was able to demonstrate that even substances that are notconsidered hapten-carrier complexes can stimulate T-cell division, i. e.
Relative to a single 308nm wavelength, more target-oriented for the melanocytes and T-cell, in addition to the continuous and low fluence treatment mode, which lead hardly pain in treatment.
RNActive cancer immunotherapies have demonstrated favorable safety profiles and immunogenicity in clinical trials for prostate cancer and lung cancer,inducing a balanced humoral and T-cell immune response.
Blinatumomab mediates the formation of a cytolytic synapse between the T-cell and the tumour cell, releasing proteolytic enzymes to kill both proliferating and resting target cells.
Therapeutic Blincyto® Blincyto®(blinatumomab) is a cancer therapy for the treatment of a rare form of acute lymphoblastic leukaemia(B-cell ALL), andthe first approved therapeutic antibody to employ so-called BiTE(bi-specific T-cell engager) technology.
In short, we were the first to describe a function for CD27 in T-cell precursors in the thymus- and the fact that Nature Immunology decided to publish our article is recognition of just how important these findings are.
Prof. Dr. Dr. Luka Cicin-Sain is the winner of the“Paper of the Month” award in September 2012.His publication“Cytomegalovirus infection impairs immune responses and accentuates T-cell pool changes observed in mice with aging” was published in the scientific journal PLOS Pathogens.
